CEP-18770 (delanzomib) in combination with dexamethasone...

Leukemia Research 2012 Vol. 36; Iss. 11

CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma

Eric Sanchez, Mingjie Li, Jennifer Li, Cathy Wang, Haiming Chen, Susan Jones-Bolin, Kathryn Hunter, Bruce Ruggeri, James R. Berenson
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Year:
2012
Language:
english
DOI:
10.1016/j.leukres.2012.07.018
File:
PDF, 594 KB
english, 2012
Conversion to is in progress
Conversion to is failed